These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31486610)

  • 1. The Utility of Colistin in Multiple Drug-Resistant
    Barut Selver Ö; Eğrilmez S; Hasanov S; Yılmaz Dağ M; Tunger A
    Turk J Ophthalmol; 2019 Sep; 49(4):220-223. PubMed ID: 31486610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of topical colistin in multiple drug-resistant Pseudomonas aeruginosa bacterial keratitis.
    Jain R; Murthy SI; Motukupally SR; Jain M
    Cornea; 2014 Sep; 33(9):923-7. PubMed ID: 25014142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensively and pan-drug resistant Pseudomonas aeruginosa keratitis: clinical features, risk factors, and outcome.
    Fernandes M; Vira D; Medikonda R; Kumar N
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):315-22. PubMed ID: 26537122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-drug resistant Pseudomonas aeruginosa keratitis and its effective treatment with topical colistimethate.
    Chatterjee S; Agrawal D
    Indian J Ophthalmol; 2016 Feb; 64(2):153-7. PubMed ID: 27050354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of clinical characteristics and antibiotic susceptibility between Pseudomonas aeruginosa and P. putida keratitis at a tertiary referral center: a retrospective study.
    Cho CH; Lee SB
    BMC Ophthalmol; 2018 Aug; 18(1):204. PubMed ID: 30126384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of topical moxifloxacin versus ciprofloxacin and vancomycin in the treatment of P. aeruginosa and ciprofloxacin-resistant MRSA keratitis in rabbits.
    Aliprandis E; Ciralsky J; Lai H; Herling I; Katz HR
    Cornea; 2005 Mar; 24(2):201-5. PubMed ID: 15725889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo challenging of polymyxins and levofloxacin eye drop against multidrug-resistant Pseudomonas aeruginosa keratitis.
    Tajima K; Miyake T; Koike N; Hattori T; Kumakura S; Yamaguchi T; Matsumoto T; Fujita K; Kuroda M; Ito N; Goto H
    J Infect Chemother; 2014 Jun; 20(6):343-9. PubMed ID: 24726376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiresistant Pseudomonas keratitis.
    Ku JY; Kim P; Tong J; Wechsler A; McCluskey P
    Clin Exp Ophthalmol; 2010 Nov; 38(8):818-9. PubMed ID: 20572829
    [No Abstract]   [Full Text] [Related]  

  • 9. Contact lens induced Pseudomonas keratitis following descemet stripping automated endothelial keratoplasty.
    Dhiman R; Singh A; Tandon R; Vanathi M
    Cont Lens Anterior Eye; 2015 Oct; 38(5):379-81. PubMed ID: 26048660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug-Resistant Pseudomonas aeruginosa Keratitis: Risk Factors, Clinical Characteristics, and Outcomes.
    Vazirani J; Wurity S; Ali MH
    Ophthalmology; 2015 Oct; 122(10):2110-4. PubMed ID: 26189185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful Management of Extensively Drug Resistant
    Dalal S; Murthy SI; Deogaokar K; Joseph J; Roy S
    Ocul Immunol Inflamm; 2024 Sep; 32(7):1279-1283. PubMed ID: 37433154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Pseudomonas keratitis in humans.
    Hessburg PC
    Am J Ophthalmol; 1966 May; 61(5 Pt 1):896-903. PubMed ID: 16874993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal colistin and sterilization of resistant Pseudomonas aeruginosa shunt infection.
    Quinn AL; Parada JP; Belmares J; O'Keefe JP
    Ann Pharmacother; 2005 May; 39(5):949-52. PubMed ID: 15811909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of virulence factors, antimicrobial resistance patterns and biofilm formation of Pseudomonas aeruginosa and Staphylococcus spp. strains isolated from corneal infection.
    Heidari H; Hadadi M; Sedigh Ebrahim-Saraie H; Mirzaei A; Taji A; Hosseini SR; Motamedifar M
    J Fr Ophtalmol; 2018 Nov; 41(9):823-829. PubMed ID: 30292385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful use of intravitreal and systemic colistin in treating multidrug resistant Pseudomonas aeruginosa post-operative endophthalmitis.
    Samant P; Ramugade S
    Indian J Ophthalmol; 2014 Dec; 62(12):1167-70. PubMed ID: 25579363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical antibiotic therapy of Pseudomonas aeruginosa keratitis.
    Kupferman A; Leibowitz HM
    Arch Ophthalmol; 1979 Sep; 97(9):1699-1702. PubMed ID: 224848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colistin in multi-drug resistant Pseudomonas aeruginosa blood-stream infections: a narrative review for the clinician.
    Martis N; Leroy S; Blanc V
    J Infect; 2014 Jul; 69(1):1-12. PubMed ID: 24631777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis.
    Mannis MJ
    Trans Am Ophthalmol Soc; 2002; 100():243-71. PubMed ID: 12545697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Features and Treatment Outcomes of Carbapenem-Resistant Pseudomonas aeruginosa Keratitis.
    Tribin FE; Lieux C; Maestre-Mesa J; Durkee H; Krishna K; Chou B; Neag E; Tóthová JD; Martinez JD; Flynn HW; Parel JM; Miller D; Amescua G
    JAMA Ophthalmol; 2024 May; 142(5):407-415. PubMed ID: 38512246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of necrotizing scleritis resulting from Pseudomonas aeruginosa.
    Moreno Honrado M; del Campo Z; Buil JA
    Cornea; 2009 Oct; 28(9):1065-6. PubMed ID: 19724201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.